4//SEC Filing
Nivalis Therapeutics, Inc. 4
Accession 0001104659-15-065277
CIK 0001626199operating
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:31 PM ET
Size
5.5 KB
Accession
0001104659-15-065277
Insider Transaction Report
Form 4
LEFF JONATHAN S
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-09-11+7,650→ 7,650 totalExercise: $15.28Exp: 2025-09-11→ Common Stock (7,650 underlying)
Footnotes (2)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]The shares shall vest in 12 equal monthly installments commencing on October 11, 2015.
Documents
Issuer
Nivalis Therapeutics, Inc.
CIK 0001626199
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001626199
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:31 PM ET
- Size
- 5.5 KB